Electrocochleography-Based Tonotopic Map: I. Place Coding of the Human Cochlea With Hearing Loss.
Amit Walia, Amanda J Ortmann, Shannon Lefler and 4 others
PMID 39233326WHAT IT FOUND
In humans with hearing loss, the cochlea's frequency map shifted nearly an octave basalward compared to standard models when stimulated at high intensities.
This suggests current clinical maps may misrepresent the cochlea's operating point during everyday listening conditions.
Key findings
01The electrophysiologically derived tonotopic map showed a discrepancy of over an octave (frequency downward or basal shift) compared to the Greenwood map in the 500 to 2000 Hz range.
02In subjects with auditory neuropathy spectrum disorder, high-intensity stimulation caused the best frequency location to shift basally, while threshold-level stimulation aligned with expected apical shifts.
03Creating an artificial 'third window' in the cochlea did not result in any shift in the frequency-position map, ruling out this surgical artifact as the cause of the observed discrepancy.
STILL TO COME
How it was doneWhat they foundWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study measured electrical responses (cochlear microphonics) as a proxy for mechanical traveling waves, which are not perfectly identical. All participants had hearing loss, so the findings apply to pathological cochleae, not normal hearing. Electrode insertion depth was limited in many subjects, preventing accurate mapping of very low frequencies (below 500 Hz) at the most apical electrodes. The intensity modulation results for the majority of subjects were confounded by their significant hearing loss and impaired outer hair cell function. The 'third window' test was conducted on a single subject undergoing a destructive procedure, limiting generalizability.
Declared interests
One author has a consultant relationship with Cochlear Ltd. Another author has equity interest in Advanced Cochlear Diagnostics, LLC, and consultant relationships with Advanced Bionics, Cochlear Ltd., Envoy, and IotaMotion. Funding included NIH grants and an American Neurotology Society Research Grant.
The easy way to misread this
Do not assume this shift applies to all patients or that current cochlear implant maps are 'wrong' in a way that requires immediate clinical protocol changes. The findings describe a biological phenomenon in hearing loss that complicates programming, but the study did not test whether adjusting maps based on these findings actually improves patient outcomes.